Please find attached a revised version (R1) of the manuscript ID HISTOP-04-10-0239 entitled "Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non Hodgkin lymphomas" by Barrena et al, which has been modified following the suggestions and comments of the reviewers.
Answer to comment 5.-The sentences presenting results in page 9 have been modified in order to more clearly describe the discrepancies observed (page 9).
REVIEWER #2
: Answer to comment 6.-Information about the specific Ki67 reagent used has been added in Supplementary Table 1b of the revised version of the manuscript, following the indication of the reviewer.
ASSOCIATE EDITOR:
There were no comments to the authors by the Associate Editor For decades now, fine-needle aspiration (FNA) cytology has been proposed as a useful tool for the diagnostic screening of patients with easily accessible enlarged lymph nodes for early, cost-effective distinction between benign/reactive and malignant disease conditions [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . More recently, combined usage of cytology and flow cytometry (FCM) immunophenotyping analysis of FNA samples has been found to contribute to an improved classification of B-cell non-Hodgkin lymphomas (B-NHL) into WHO categories, specially for low grade B-cell lymphomas [11] [12] [13] [16] [17] [18] [19] [20] . In contrast, the accuracy of FNA alone vs excisional biopsy for both primary diagnosis and classification of malignant lymphoma remains controversial [21] [22] [23] [24] . Although many studies have reported concordance rates between FNA-studies and histology of >80% (range: 76% to 97%) 6, 10, 12-13, 16, 18-19, 25-31 , it is recommended that analysis of FNA samples should not replace tissue biopsy studies, because of the existence of false negative cases in all reported series. In turn, very heterogeneous results have been reported regarding the contribution of FNA studies vs lymph node histology for the diagnostic subclassification of B-NHL with concordance rates of between <50% to 87%, depending on the type of lymphoma 12-13, 16-20, 28 ; in this regard FNA-based studies are frequently considered to be of limited utility for the classification of lymphoma, because they do not provide information on the histology of the tumor 24, [32] [33] [34] 2, 5, 7, 30, 35 . In addition, the information about the independent value of FMC immunophenotyping versus conventional cytological analyses of FNA samples on the diagnostic screening of lymphoma is limited 13, 20, 25, [36] [37] , as most reports have focused on the utility of FNA cytology combined with FCM vs histopathology.
In this study we prospectively evaluated the potential contribution of FCM immunophenotyping (vs conventional cytological and histological studies) in the diagnostic screening of FNA samples, and, in further subclassification of B-NHL into specific WHO categories. Cytomorphologic and immunocytochemical analyses. FNA specimens were collected by an experienced cytopathologist, using 20-mL syringes equipped with a syringed holder and a 23 gauge-needle (0.6 x 25mm), as described elsewhere 16, [38] [39] [40] .
MATERIAL AND METHODS

Patients and samples.
Either 2 or 3 air-dried, ethanol-fixed smears were stained from each FNA sample using Papanicolaou and/or haematoxylin-eosin (H&E) [41] [42] [43] [44] , for conventional cytological analyses. Whenever indicated, immunocytochemistry was performed for disease classification after smears had been fixed with methanol and stained, with appropriate monoclonal antibodies (MAb) as previously described 45 (supplementary Table 1b ). All slides were assessed by an experienced cytopathologist.
Immunophenotypic studies. Half of each FNA specimen was placed in 1ml of a sterile saline solution, and immediately processed for further FCM immunophenotyping. Briefly, samples (100µL) were stained using a direct immunofluorescence stain-and-then-lyse technique, previously described in detail 46 Table 1a ). In addition to the MAb reagents, 100µL of premixed Perfect Count TM beads (Cytognos SL, Salamanca, Spain) were added to each stained specimen immediately prior to its FCM measurement, to calculate absolute cell counts [47] [48] . After staining, samples were run at low speed on either a FACSCalibur or a Briefly, tissue specimens were fixed in 10% formaldehyde, embedded in paraffin and sliced into 3 µm-sections. Afterward, specimens were stained with H&E and evaluated with an optical microscope (Nikon Y-THM, Tokio, Japan) using conventional approaches. Whenever appropriate, tissue sections were also stained by conventional immunohistochemistry (immunoperoxidase technique) 50 using an immunostainer (Vision Biosystem, Newcastle, UK), with the MAb listed in the immunohistochemistry section of Supplementary Table 1b . Appropriate positive and negative controls were used in parallel. Two experienced pathologists routinely evaluated the slides; in addition, in case of any discrepancy (between histology, FCM and/or cytology), specimens were further reviewed a third time−and whenever required, frozen tissue sections re-stained−, to confirm the histological diagnosis.
Analysis of TCR and IGH gene rearrangements.
In those samples in which discrepant diagnostic findings were obtained between FCM, cytology and/or histology, and either B-or T-cell clonality was suspected by one or more methods, TCRG and IGH gene rearrangements were assessed by well-established polymerase chain reaction (PCR) techniques 51 , using the BIOMED-2 TCRG 52 and combined IGH and IGK genebased probes and protocols, respectively 53 . Table 2 ) and to the BL-like clone from case #6 (see Table 2 ); both B-cell populations were detected by FCM but not by histology. (Table 4) .
Interphase fluorescence in situ hybridization
Role of FCM immunophenotyping of FNA samples vs histopathology in the sub-classification of B-NHL into WHO categories.
Overall, the assignment of B-NHL to specific WHO diagnostic categories provided by FCM (vs histopathology) was confirmed in 10/18 discrepant cases (56% vs 38%), corresponding to 12/21 samples (57% vs 33%). Accordingly, FCM showed a greater sensitivity (91%; range: 94% to 100%) than histopathology (84%; range: 75% to 100%)
for the majority of B-NHL subgroups ( Table 3) including FL (94% vs 87%), DLBCL (100% vs 79%), and BL (100% vs 75%). In contrast, the sensitivity of histopathology was higher than that of FCM (67% vs 33%) for MALT and marginal zone lymphomas.
In turn, the specificity of FCM was similar to that of histopathology (range: 98%-100%
vs 92%-100%, respectively) for all WHO groups of B-NHL ( Table 2 Discordant results between FCM, conventional cytology and histopathology at diagnostic screening Table 3 Sensitivity ( 
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Flow cytometry distribution of lymphocyte subsets in lymph node FNA samples with concordant diagnoses (n=323).
Overall, FNA samples infiltrated with T-NHL showed a significantly (p<0.04) higher percentage of T cells than those corresponding to B-NHL, ST, PCM and T-ALL, but similar to those from individuals with RP and HL (p>0.05) ( Figure 1A) . A similar distribution to that of mature CD3+ T lymphocytes was also found among the different diagnostic groups for the major CD4+, and to a lower extent, also CD8+ T-cell subsets (Figure 1 B-C) . HL showed the highest CD4 + /CD8 + T-cell ratio values, which were significantly greater than those of RP, B-NHL and PCM samples ( Figure 1F ). The minor CD4+/CD8+ and CD4-/CD8-T-cell phenotypes were particularly increased among T-NHL specimens. (Figures 1 D-E) Overall, B cell numbers were significantly higher among B-NHL vs all other groups (p≤0.01; Figure 1G ). In addition, once sIgκ 
